See more : Life’s Time Capsule Services, Inc. (LTCP) Income Statement Analysis – Financial Results
Complete financial analysis of Global Partners LP (GLP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Partners LP, a leading company in the Oil & Gas Midstream industry within the Energy sector.
- Macpower CNC Machines Limited (MACPOWER.NS) Income Statement Analysis – Financial Results
- Indergiri Finance Limited (INDERGR.BO) Income Statement Analysis – Financial Results
- High North Resources Ltd. (HNTHF) Income Statement Analysis – Financial Results
- Element79 Gold Corp. (ELEM.CN) Income Statement Analysis – Financial Results
- Keiyo Co., Ltd. (8168.T) Income Statement Analysis – Financial Results
Global Partners LP (GLP)
About Global Partners LP
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid-Atlantic region, and New York. The company is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Its Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, residual oil, and propane to home heating oil retailers and wholesale distributors. It also aggregates crude oil through truck or pipeline in the mid-continent region of the United States and Canada, as well as transports it through rail and ships it through barge to refiners. The company's Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. Its Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. As of December 31, 2021, the company had a portfolio of 1,595 owned, leased, and supplied gasoline stations, which included 295 directly operated convenience stores; and owned, leased, or maintained storage facilities at 26 bulk terminals with a collective storage capacity of 11.9 million barrels. Global GP LLC serves as the general partner of the company. The company was incorporated in 2005 and is based in Waltham, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 16.49B | 18.88B | 13.25B | 8.32B | 13.08B | 12.67B | 8.92B | 8.24B | 10.31B | 17.27B | 19.59B | 17.63B | 14.84B | 7.80B | 5.82B | 9.02B | 6.76B | 4.47B | 1.25B | 3.19B | 2.48B | 1.59B | 1.75B |
Cost of Revenue | 15.98B | 17.78B | 12.53B | 7.60B | 12.42B | 12.02B | 8.34B | 7.69B | 9.72B | 16.73B | 19.18B | 17.29B | 14.63B | 7.63B | 5.67B | 8.90B | 6.63B | 4.36B | 1.22B | 3.11B | 2.41B | 1.54B | 1.69B |
Gross Profit | 513.83M | 1.10B | 719.26M | 721.14M | 662.76M | 650.41M | 583.05M | 546.49M | 597.67M | 542.61M | 405.83M | 333.49M | 209.60M | 166.72M | 149.83M | 119.79M | 126.98M | 113.23M | 28.91M | 75.87M | 67.10M | 55.20M | 62.50M |
Gross Profit Ratio | 3.12% | 5.81% | 5.43% | 8.67% | 5.07% | 5.13% | 6.54% | 6.63% | 5.79% | 3.14% | 2.07% | 1.89% | 1.41% | 2.14% | 2.58% | 1.33% | 1.88% | 2.53% | 2.31% | 2.38% | 2.71% | 3.46% | 3.56% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 273.73M | 263.11M | 212.88M | 192.53M | 170.94M | 171.00M | 155.03M | 149.67M | 177.04M | 153.96M | 115.49M | 101.46M | 152.14M | 113.84M | 96.09M | 73.85M | 73.24M | 65.19M | 15.44M | 53.04M | 30.30M | 27.50M | 26.80M |
Other Expenses | 0.00 | 454.12M | 364.29M | 334.14M | 353.81M | 279.45M | 309.05M | 297.94M | 303.81M | 222.94M | 204.93M | 147.44M | 4.80M | 3.53M | 2.99M | 2.88M | 2.25M | 1.53M | 390.00K | 4.79M | 18.80M | 17.70M | 0.00 |
Operating Expenses | 266.33M | 717.23M | 577.17M | 526.67M | 524.75M | 450.45M | 464.08M | 447.61M | 480.85M | 376.90M | 320.42M | 248.90M | 156.94M | 117.37M | 99.08M | 76.73M | 75.49M | 66.71M | 15.83M | 57.82M | 49.10M | 45.20M | 26.80M |
Cost & Expenses | 16.25B | 18.50B | 13.11B | 8.13B | 12.94B | 12.47B | 8.80B | 8.14B | 10.20B | 17.10B | 19.50B | 17.54B | 14.78B | 7.75B | 5.77B | 8.98B | 6.71B | 4.43B | 1.24B | 3.17B | 2.46B | 1.58B | 1.72B |
Interest Income | 0.00 | 81.26M | 80.09M | 83.54M | 89.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 85.63M | 81.26M | 80.09M | 83.54M | 89.86M | 89.15M | 86.23M | 86.32M | 73.33M | 47.76M | 43.54M | 36.27M | 31.21M | 22.31M | 15.19M | 20.80M | 17.41M | 11.90M | 2.69M | 4.70M | 2.00M | 2.20M | 3.00M |
Depreciation & Amortization | 110.09M | 104.80M | 102.24M | 100.14M | 108.19M | 106.84M | 105.65M | 111.94M | 13.50M | 18.87M | 19.22M | 45.46M | 30.36M | 20.08M | 2.99M | 15.13M | 9.61M | 4.11M | 953.00K | 3.23M | 0.00 | -1.10M | 26.07M |
EBITDA | 356.36M | 565.08M | 244.46M | 285.24M | 234.32M | 304.01M | 225.44M | -42.11M | 114.72M | 252.07M | 161.27M | 130.05M | 85.71M | 69.43M | 53.74M | 43.01M | 51.49M | 46.51M | 14.03M | 21.28M | 18.00M | 8.90M | 35.70M |
EBITDA Ratio | 2.16% | 2.06% | 1.15% | 2.47% | 1.14% | 1.66% | 1.44% | 1.31% | 1.26% | 1.07% | 0.53% | 0.74% | 0.56% | 0.89% | 0.92% | 0.65% | 0.70% | 1.12% | 1.12% | 0.67% | 0.73% | 0.56% | 2.04% |
Operating Income | 243.77M | 460.29M | 142.22M | 192.27M | 139.21M | 197.17M | 119.78M | -152.25M | 114.72M | 165.71M | 85.41M | 84.59M | 50.63M | 49.35M | 50.75M | 43.07M | 51.49M | 46.51M | 13.08M | 18.05M | 18.00M | 10.00M | 19.90M |
Operating Income Ratio | 1.48% | 2.44% | 1.07% | 2.31% | 1.06% | 1.56% | 1.34% | -1.85% | 1.11% | 0.96% | 0.44% | 0.48% | 0.34% | 0.63% | 0.87% | 0.48% | 0.76% | 1.04% | 1.05% | 0.57% | 0.73% | 0.63% | 1.13% |
Total Other Income/Expenses | -83.13M | -81.26M | -80.09M | -90.70M | -102.94M | -89.15M | -86.23M | -86.32M | -73.33M | -47.76M | -43.54M | -36.27M | -31.21M | -22.31M | -15.19M | -20.80M | -3.29M | -11.39M | 6.01M | 0.00 | -2.00M | -4.00M | 700.00K |
Income Before Tax | 160.64M | 379.03M | 62.13M | 101.56M | 36.27M | 108.03M | 33.55M | -238.57M | 41.39M | 117.94M | 41.87M | 48.32M | 19.42M | 27.04M | 35.56M | 22.21M | 48.20M | 35.13M | 10.39M | 0.00 | 16.00M | 6.00M | 20.60M |
Income Before Tax Ratio | 0.97% | 2.01% | 0.47% | 1.22% | 0.28% | 0.85% | 0.38% | -2.90% | 0.40% | 0.68% | 0.21% | 0.27% | 0.13% | 0.35% | 0.61% | 0.25% | 0.71% | 0.79% | 0.83% | 0.00% | 0.65% | 0.38% | 1.17% |
Income Tax Expense | 8.14M | 16.82M | 1.34M | -119.00K | 1.09M | 5.62M | -23.56M | 53.00K | -1.87M | 963.00K | 819.00K | 1.58M | 68.00K | 0.00 | 1.43M | 1.15M | 1.19M | 1.67M | 986.00K | 739.54K | 0.00 | 5.10M | -10.27M |
Net Income | 152.51M | 362.21M | 60.80M | 102.21M | 35.87M | 103.91M | 58.75M | -199.41M | 43.56M | 114.71M | 42.62M | 46.74M | 19.35M | 27.04M | 33.34M | 21.06M | 47.01M | 33.46M | 9.41M | 17.31M | 16.00M | 6.00M | 20.60M |
Net Income Ratio | 0.92% | 1.92% | 0.46% | 1.23% | 0.27% | 0.82% | 0.66% | -2.42% | 0.42% | 0.66% | 0.22% | 0.27% | 0.13% | 0.35% | 0.57% | 0.23% | 0.70% | 0.75% | 0.75% | 0.54% | 0.65% | 0.38% | 1.17% |
EPS | 3.77 | 10.06 | 1.79 | 2.77 | 0.82 | 3.08 | 1.74 | -5.95 | 1.12 | 3.97 | 1.43 | 1.73 | 0.88 | 1.61 | 2.56 | 1.57 | 1.38 | 2.46 | 1.60 | 3.07 | 2.84 | 1.06 | 3.65 |
EPS Diluted | 3.76 | 10.02 | 1.77 | 2.74 | 0.81 | 3.06 | 1.74 | -5.95 | 1.11 | 3.95 | 1.42 | 1.71 | 0.87 | 1.59 | 2.51 | 1.57 | 1.38 | 2.46 | 1.60 | 3.07 | 2.84 | 1.06 | 3.65 |
Weighted Avg Shares Out | 33.97M | 33.94M | 33.94M | 33.91M | 33.81M | 33.70M | 33.59M | 33.52M | 32.18M | 27.42M | 27.33M | 26.39M | 21.28M | 16.35M | 13.02M | 13.07M | 12.44M | 11.29M | 5.64M | 5.64M | 5.64M | 5.64M | 5.64M |
Weighted Avg Shares Out (Dil) | 34.04M | 34.04M | 34.28M | 34.31M | 34.34M | 33.97M | 33.63M | 33.53M | 32.32M | 27.50M | 27.56M | 26.57M | 21.47M | 16.60M | 13.28M | 13.07M | 12.44M | 11.29M | 5.64M | 5.64M | 5.64M | 5.64M | 5.64M |
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks
Global Partners LP Common Units (GLP) Q3 2024 Earnings Call Transcript
Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024
Global Partners Reports Third-Quarter 2024 Financial Results
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
Hims & Hers Health CFO talks GLP-1s, earnings
Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
Source: https://incomestatements.info
Category: Stock Reports